156 related articles for article (PubMed ID: 11083631)
1. Influence of human sera on the in vitro activity of the echinocandin caspofungin (MK-0991) against Aspergillus fumigatus.
Chiller T; Farrokhshad K; Brummer E; Stevens DA
Antimicrob Agents Chemother; 2000 Dec; 44(12):3302-5. PubMed ID: 11083631
[TBL] [Abstract][Full Text] [Related]
2. The interaction of human monocytes, monocyte-derived macrophages, and polymorphonuclear neutrophils with caspofungin (MK-0991), an echinocandin, for antifungal activity against Aspergillus fumigatus.
Chiller T; Farrokhshad K; Brummer E; Stevens DA
Diagn Microbiol Infect Dis; 2001 Feb; 39(2):99-103. PubMed ID: 11248522
[TBL] [Abstract][Full Text] [Related]
3. The antifungal echinocandin caspofungin acetate kills growing cells of Aspergillus fumigatus in vitro.
Bowman JC; Hicks PS; Kurtz MB; Rosen H; Schmatz DM; Liberator PA; Douglas CM
Antimicrob Agents Chemother; 2002 Sep; 46(9):3001-12. PubMed ID: 12183260
[TBL] [Abstract][Full Text] [Related]
4. Comparative in vitro pharmacodynamics of caspofungin, micafungin, and anidulafungin against germinated and nongerminated Aspergillus conidia.
Antachopoulos C; Meletiadis J; Sein T; Roilides E; Walsh TJ
Antimicrob Agents Chemother; 2008 Jan; 52(1):321-8. PubMed ID: 17938191
[TBL] [Abstract][Full Text] [Related]
5. Influences of methodological variables on susceptibility testing of caspofungin against Candida species and Aspergillus fumigatus.
Bartizal C; Odds FC
Antimicrob Agents Chemother; 2003 Jul; 47(7):2100-7. PubMed ID: 12821453
[TBL] [Abstract][Full Text] [Related]
6. Sequential exposure of Aspergillus fumigatus to itraconazole and caspofungin: evidence of enhanced in vitro activity.
Kontoyiannis DP; Lewis RE; Lionakis MS; Albert ND; May GS; Raad II
Diagn Microbiol Infect Dis; 2003 Oct; 47(2):415-9. PubMed ID: 14522515
[TBL] [Abstract][Full Text] [Related]
7. Serum differentially alters the antifungal properties of echinocandin drugs.
Paderu P; Garcia-Effron G; Balashov S; Delmas G; Park S; Perlin DS
Antimicrob Agents Chemother; 2007 Jun; 51(6):2253-6. PubMed ID: 17420211
[TBL] [Abstract][Full Text] [Related]
8. In-vitro activity of nikkomycin Z alone and in combination with polyenes, triazoles or echinocandins against Aspergillus fumigatus.
Ganesan LT; Manavathu EK; Cutright JL; Alangaden GJ; Chandrasekar PH
Clin Microbiol Infect; 2004 Nov; 10(11):961-6. PubMed ID: 15521997
[TBL] [Abstract][Full Text] [Related]
9. Stress-Induced Changes in the Lipid Microenvironment of β-(1,3)-d-Glucan Synthase Cause Clinically Important Echinocandin Resistance in Aspergillus fumigatus.
Satish S; Jiménez-Ortigosa C; Zhao Y; Lee MH; Dolgov E; Krüger T; Park S; Denning DW; Kniemeyer O; Brakhage AA; Perlin DS
mBio; 2019 Jun; 10(3):. PubMed ID: 31164462
[No Abstract] [Full Text] [Related]
10. Caspofungin modulates inflammatory responses to Aspergillus fumigatus through stage-specific effects on fungal beta-glucan exposure.
Hohl TM; Feldmesser M; Perlin DS; Pamer EG
J Infect Dis; 2008 Jul; 198(2):176-85. PubMed ID: 18500928
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of broth microdilution testing parameters and agar diffusion Etest procedure for testing susceptibilities of Aspergillus spp. to caspofungin acetate (MK-0991).
Espinel-Ingroff A
J Clin Microbiol; 2003 Jan; 41(1):403-9. PubMed ID: 12517880
[TBL] [Abstract][Full Text] [Related]
12. Differential activity of triazoles in two-drug combinations with the echinocandin caspofungin against Aspergillus fumigatus.
Manavathu EK; Alangaden GJ; Chandrasekar PH
J Antimicrob Chemother; 2003 Jun; 51(6):1423-5. PubMed ID: 12716776
[TBL] [Abstract][Full Text] [Related]
13. The Paradoxical Effect of Echinocandins in Aspergillus fumigatus Relies on Recovery of the β-1,3-Glucan Synthase Fks1.
Loiko V; Wagener J
Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27872079
[TBL] [Abstract][Full Text] [Related]
14. In vitro preclinical evaluation studies with the echinocandin antifungal MK-0991 (L-743,872).
Bartizal K; Gill CJ; Abruzzo GK; Flattery AM; Kong L; Scott PM; Smith JG; Leighton CE; Bouffard A; Dropinski JF; Balkovec J
Antimicrob Agents Chemother; 1997 Nov; 41(11):2326-32. PubMed ID: 9371328
[TBL] [Abstract][Full Text] [Related]
15. Combined action of micafungin, a new echinocandin, and human phagocytes for antifungal activity against Aspergillus fumigatus.
Choi JH; Brummer E; Stevens DA
Microbes Infect; 2004 Apr; 6(4):383-9. PubMed ID: 15050966
[TBL] [Abstract][Full Text] [Related]
16. Assessing the antifungal activity, pharmacokinetics, and tissue distribution of amphotericin B following the administration of Abelcet and AmBisome in combination with caspofungin to rats infected with Aspergillus fumigatus.
Wasan KM; Sivak O; Rosland M; Risovic V; Bartlett K
J Pharm Sci; 2007 Jul; 96(7):1737-47. PubMed ID: 17080414
[TBL] [Abstract][Full Text] [Related]
17. Synergy, pharmacodynamics, and time-sequenced ultrastructural changes of the interaction between nikkomycin Z and the echinocandin FK463 against Aspergillus fumigatus.
Chiou CC; Mavrogiorgos N; Tillem E; Hector R; Walsh TJ
Antimicrob Agents Chemother; 2001 Dec; 45(12):3310-21. PubMed ID: 11709302
[TBL] [Abstract][Full Text] [Related]
18. Characterization of Aspergillus fumigatus mutants with reduced susceptibility to caspofungin.
Gardiner RE; Souteropoulos P; Park S; Perlin DS
Med Mycol; 2005 May; 43 Suppl 1():S299-305. PubMed ID: 16110824
[TBL] [Abstract][Full Text] [Related]
19. Quantitative PCR assay to measure Aspergillus fumigatus burden in a murine model of disseminated aspergillosis: demonstration of efficacy of caspofungin acetate.
Bowman JC; Abruzzo GK; Anderson JW; Flattery AM; Gill CJ; Pikounis VB; Schmatz DM; Liberator PA; Douglas CM
Antimicrob Agents Chemother; 2001 Dec; 45(12):3474-81. PubMed ID: 11709327
[TBL] [Abstract][Full Text] [Related]
20. The effects of antifungal agents to conidial and hyphal forms of Aspergillus fumigatus.
van de Sande WW; Tavakol M; van Vianen W; Bakker-Woudenberg IA
Med Mycol; 2010 Feb; 48(1):48-55. PubMed ID: 20055743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
